Egypt - engelsk - EDA (Egyptian Drug Authority)

3a pharma - egypt - neomycin sulphate 200mg ( eq. to neomycin base 140 mg ) /1ml - oral solution

Egypt - engelsk - EDA (Egyptian Drug Authority)

3a pharma - tiamulin hydrogen fumarate 12.5 gm (eq. to tiamulin base 10.12 gm) /100ml - oral solution

Egypt - engelsk - EDA (Egyptian Drug Authority)

3a pharma - toltrazuril 2.5 gm /100ml - oral solution

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - mercaptopurine monohydrate 50mg; mercaptopurine monohydrate 50mg - tablet - 50 mg - active: mercaptopurine monohydrate 50mg excipient: lactose monohydrate magnesium stearate maize starch stearic acid active: mercaptopurine monohydrate 50mg excipient: lactose monohydrate magnesium stearate maize starch stearic acid - puri-nethol is indicated for the treatment of acute leukaemia. it may be utilised in remission induction and is particularly indicated for maintenance therapy in: · acute lymphoblastic leukaemia; · acute myelogenous leukaemia.

Israel - engelsk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - rifabutin - capsules - rifabutin 150 mg - rifabutin - rifabutin - for the treatment of chronic tuberculosis where there is evidence of acid fast bacteria resistant to rifampicin or to two other alternative drugs. for the treatment of infections caused by mac or other atypical mycobacteria where there is evidence of resistant bacteria as above. for the treatment of infections caused by mac or other atypical mycobacteria in aids patients in all cases not subject to the above restrictions. for prevention of mac infections in aids patients whose cd4 counts lower or eqval to 200/mm3

Israel - engelsk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - irinotecan hydrochloride - solution for infusion - irinotecan hydrochloride 20 mg/ml - irinotecan - irinotecan - campto is indicated for the treatment of patients with metastatic colorectal cancer: in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.irinotecan in combination with leucovorin, oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma.

Israel - engelsk - Ministry of Health

padagis israel pharmaceuticals ltd, israel - alprazolam - tablets - alprazolam 0.5 mg - alprazolam - alprazolam - treatment of anxiety accompanied by depression. treatment of panic states with or without accompanying phobia.

Israel - engelsk - Ministry of Health

padagis israel pharmaceuticals ltd, israel - alprazolam - tablets - alprazolam 1 mg - alprazolam - alprazolam - treatment of anxiety accompanied by depression. treatment of panic states with or without accompanying phobia.

Israel - engelsk - Ministry of Health

padagis israel pharmaceuticals ltd, israel - alprazolam - tablets - alprazolam 0.25 mg - alprazolam - alprazolam - treatment of anxiety accompanied by depression. treatment of panic states with or without accompanying phobia.

Israel - engelsk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprazolam - tablets sustained release - alprazolam 0.5 mg - alprazolam - alprazolam - for the treatment of anxiety and anxiety associated with depression.treatment of panic disorder with or without phobic avoidance